precision-immunology techbio
Graph Therapeutics has raised $5.0M in total funding. The most recent round was Seed. The last funding was announced in June 2026.
Graph Therapeutics's investors include Daphni, Merantix Capital, SquareOne Venture Capital, Mehdi Ghissassi, austria Wirtschaftsservice (aws).
Graph Therapeutics is headquartered in Vienna, Austria.
precision-immunology techbio
Graph Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Graph Therapeutics — Funding & Investors." VCBacked, June 22, 2026, https://www.vcbacked.co/company/graph-therapeutics. Accessed November 15, 2026.
VCBacked. (2026). Graph Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/graph-therapeutics
{{cite web |title=Graph Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/graph-therapeutics |website=VCBacked |access-date=November 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Graph Therapeutics? Request a listing update